[1] Ma C, Han M, Heinrich B, et al. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells[J]. Science,2018,360(6391):eaan5931.
[2] Yu LX, Schwabe RF. The gut microbiome and liver cancer: mechanisms and clinical translation[J]. Nat Rev Gastroenterol Hepatol,2017,14(9):527-539.
[3] Tripathi A, Debelius J, Brenner DA, et al. The gut-liver axis and the intersection with the microbiome[J]. Nat Rev Gastroenterol Hepatol,2018,15(7):397-411.
[4] Tsilimigras MC, Fodor A, Jobin C. Carcinogenesis and therapeutics: the microbiota perspective[J]. Nat Microbiol,2017,2(3):17008.
[5] Poore GD, Kopylova E, Zhu Q, et al. Microbiome analyses of blood and tissues suggest cancer diagnostic approach[J]. Nature,2020,579(7800):567-574.
[6] Nejman D, Livyatan I, Fuks G, et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria[J]. Science,2020,368(6494):973-980.
[7] Komiyama S, Yamada T, Takemura N, et al. Profiling of tumour-associated microbiota in human hepatocellular carcinoma[J]. Sci Rep,2021,11(1):10589.
[8] Qu D, Wang Y, Xia Q, et al. Intratumoral Microbiome of Human Primary Liver Cancer[J]. Hepatol Commun,2022,6(7):1741-1752.
[9] Li S, Xia H, Wang Z, et al. Intratumoral microbial heterogeneity affected tumor immune microenvironment and determined clinical outcome of HBV-related HCC[J]. Hepatology,2023,78(4):1079-1091.
[10] Fu A, Yao B, Dong T, et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer[J]. Cell,2022,185(8):1356-1372.e26.
[11] Ghaddar B, Biswas A, Harris C, et al. Tumor microbiome links cellular programs and immunity in pancreatic cancer[J]. Cancer cell,2022,40(10):1240-1253.e5.
[12] Duan Y, Llorente C, Lang S, et al. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease[J]. Nature,2019,575(7783):505-511. |
